⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HCM News
HUTCHMED (China) Limited American Depositary Shares
HUTCHMED Highlights SAFFRON Global Phase III Data Presented at ESMO Congress 2026 and Simultaneously Published in The New England Journal of Medicine
globenewswire.com
HCM
AZN
HUTCHMED Announces Closing of KRAS-EGFR-Antibody Conjugate Therapy License to GSK Outside China
globenewswire.com
HCM
HUTCHMED Initiates Global Trial of KRAS-EGFR-Antibody Conjugate Therapy HMPL-A830 in Patients with Solid Tumors
globenewswire.com
HCM
GSK
HUTCHMED Highlights Clinical Data to be Presented at the ESMO Congress 2026
globenewswire.com
HCM
LLY
AZN
HUTCHMED Announces Licensing Agreement with GSK for KRAS-EGFR-Antibody Conjugate Cancer Therapy
globenewswire.com
HCM
HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit of ORPATHYS® Plus TAGRISSO® in Treatment-Naïve Patients with MET-Overexpressing EGFR-mutated Lung Cancer in China
globenewswire.com
HCM
AZN
HUTCHMED Announces NMPA Approval for ATLED® (Fanregratinib) for the Treatment of Patients with FGFR2-Fusion/Rearrangement Intrahepatic Cholangiocarcinoma
globenewswire.com
HCM
HUTCHMED Reports 2026 Interim Results
globenewswire.com
HCM
LLY
AZN
TMDX
HUTCHMED to Announce 2026 Half-Year Financial Results
globenewswire.com
HCM
HUTCHMED Highlights Clinical Data to be Presented at the 2026 ASCO Annual Meeting
globenewswire.com
HCM